Instrument Inactif

Autres langues BROE CAPI

Actions

BCAC

US11374E1047

Autres langues

18/08/22	BROE CAPI27 : INDEX TO UNAUDITED CONDENSED FINANCIAL STATEMENTS - Form 8-K/A
18/08/22	Brookline Capital Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
04/08/22	BROE CAPI27 : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K
01/08/22	Brookline Capital Acquisition : Apexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology Company - Form 8-K
29/07/22	Brookline Capital Acquisition Corp.(NasdaqCM:BCAC) dropped from NASDAQ Composite Index
29/07/22	Apexigen Inc. completed the acquisition of Brookline Capital Acquisition Corp. from Brookline Capital Holdings, LLC, Periscope Capital Inc, Kepos Capital LP and others in a reverse merger transaction.
28/07/22	BROOKLINE CAPITAL ACQUISITION : AND APEXIGEN, INC. ANNOUNCE STOCKHOLDER APPROVAL OF BUSINESS COMBINATION - Form 8-K
18/07/22	Brookline Capital Acquisition : Apexigen and Brookline Capital Acquisition Corp. Announce Effectiveness of Registration Statement and Annual Stockholder Meeting to Approve the Proposed Business Combination - Form 8-K
30/06/22	Brookline Capital Acquisition : Confirms Receipt of Sponsor Funds to Extend Period of Time to Consummate Business Combination and for Additional Working Capital - Form 8-K
23/05/22	Brookline Capital Acquisition : Quarterly Report (Form 10-Q)
23/05/22	Brookline Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
02/05/22	Brookline Capital Acquisition Corp. announced that it has received $0.167032 million in funding from Brookline Capital Holdings, LLC
27/04/22	Brookline Capital Acquisition : Announces Stockholder Approval of Extension Amendment to Complete its Business Combination with Apexigen, Inc - Form 8-K
07/04/22	Brookline Capital Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021
07/04/22	Brookline Capital Acquisition Corp. Auditor Raises 'Going Concern' Doubt
18/03/22	Brookline Capital Acquisition : VIAVID communications simplified. Apexigen and Brookline Capital Acquisition Corp. Joint Conference Call - Form 8-K
18/03/22	Brookline Capital Acquisition : Apexigen and Brookline Capital Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Immuno-oncology Company - Form 8-K
18/03/22	Blank Check Firm Brookline Capital Acquisition, Apexigen Enter Merger Agreement
18/03/22	Apexigen Inc. entered into a non-binding letter of intent to acquire Brookline Capital Acquisition Corp. from Brookline Capital Holdings, LLC, Periscope Capital Inc, Kepos Capital LP and others for approximately $210 million in a reverse merger transaction.
15/12/21	Brookline Capital Acquisition : Delisting/Failure to Satisfy Listing Rule/Transfer of Listing - Form 8-K
24/11/21	Brookline Capital Acquisition : Amendment to Current Report (Form 8-K/A)
16/08/21	Brookline Capital Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021
27/07/21	Certain Common Stock of Brookline Capital Acquisition Corp. are subject to a Lock-Up Agreement Ending on 27-JUL-2021.
07/06/21	Brookline Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021
07/06/21	Brookline Capital Acquisition : Quarterly Report (SEC Filing - 10-Q)